Education
About Us
Working with TipRanks
Follow Us
Aytu BioScience Inc (AYTU)
NASDAQ:AYTU
Total Valuation
Aytu BioScience has a market cap or net worth of $21.11M. The enterprise value is $6.79M.
Market Cap$21.11M
Enterprise Value$6.79M
Share Statistics
Aytu BioScience has 9,911,913 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,911,913
Owned by Insiders4.20%
Owned by Institutions28.96%
Financial Efficiency
Aytu BioScience’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -11.19%.
Return on Equity (ROE)-0.72
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-11.19%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee650.80K
Profits Per Employee-132.96K
Employee Count102
Asset Turnover0.53
Inventory Turnover1.80
Valuation Ratios
The current PE Ratio of Aytu BioScience is ―. Aytu BioScience’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.21
PB Ratio0.72
Price to Fair Value0.72
Price to FCF-6.32
Price to Operating Cash Flow-7.42
PEG Ratio0.04
Income Statement
In the last 12 months, Aytu BioScience had revenue of 66.38M and earned -13.56M in profits. Earnings per share was -2.16.
Revenue66.38M
Gross Profit45.83M
Operating Income-7.83M
Pretax Income-13.74M
Net Income-13.56M
EBITDA-4.67M
Earnings Per Share (EPS)-2.16
Cash Flow
In the last 12 months, operating cash flow was -1.36M and capital expenditures -92.00K, giving a free cash flow of -1.46M billion.
Operating Cash Flow-1.36M
Free Cash Flow-1.46M
Free Cash Flow per Share-0.15
Dividends & Yields
Aytu BioScience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.80
52-Week Price Change34.36%
50-Day Moving Average2.16
200-Day Moving Average1.88
Relative Strength Index (RSI)55.23
Average Volume (3m)314.73K
Important Dates
Aytu BioScience upcoming earnings date is Feb 18, 2026, TBA (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateFeb 18, 2026
Ex-Dividend Date―
Financial Position
Aytu BioScience as a current ratio of 1.26, with Debt / Equity ratio of 120.94%
Current Ratio1.26
Quick Ratio1.07
Debt to Market Cap1.59
Net Debt to EBITDA1.72
Interest Coverage Ratio-2.11
Taxes
In the past 12 months, Aytu BioScience has paid 437.00K in taxes.
Income Tax437.00K
Effective Tax Rate-0.03
Enterprise Valuation
Aytu BioScience EV to EBITDA ratio is -1.22, with an EV/FCF ratio of -2.62.
EV to Sales0.09
EV to EBITDA-1.22
EV to Free Cash Flow-2.62
EV to Operating Cash Flow-2.93
Balance Sheet
Aytu BioScience has $32.63M in cash and marketable securities with $1.86M in debt, giving a net cash position of $30.77M billion.
Cash & Marketable Securities$32.63M
Total Debt$1.86M
Net Cash$30.77M
Net Cash Per Share$3.10
Tangible Book Value Per Share-$3.70
Margins
Gross margin is 69.04%, with operating margin of -11.79%, and net profit margin of -20.43%.
Gross Margin69.04%
Operating Margin-11.79%
Pretax Margin-20.71%
Net Profit Margin-20.43%
EBITDA Margin-7.03%
EBIT Margin-15.13%
Analyst Forecast
The average price target for Aytu BioScience is $9.17, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$9.17
Price Target Upside318.72% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast-15.61%
EPS Growth Forecast-68.96%